Brasília – The National Cancer Institute (INCA) announces a pilot study to evaluate the feasibility of implementing a lung cancer screening program within the Unified Health System (SUS). Conducted in partnership with the Rio de Janeiro municipal health authority and supported by AstraZeneca, the initiative aims to generate evidence for a future national guideline focused on early detection and mortality reduction.

The two-year study will initially include at least 397 high-risk participants—primarily smokers or former smokers—and will use low-dose computed tomography (LDCT), a method associated with a 20% reduction in lung cancer mortality, rising to 38% when combined with smoking cessation. Currently, lung cancer screening is not part of national guidelines, despite evidence showing it can significantly reduce late-stage diagnoses.

Source: JOTA